Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 8.69x is 16% below its 5-year average of 10.37x, near the low end of its 5-year range (6.92x–18.77x).
0.82% below its 12-month average of 8.76x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2026 (2026-06-30): 7.96x.
INTEREST COVERAGE RATIO
8.69x
INTEREST COVERAGE RATIO AVG TTM
8.76x
INTEREST COVERAGE RATIO AVG 3Y
9.85x
INTEREST COVERAGE RATIO AVG 5Y
10.37x
INTEREST COVERAGE RATIO AVG 10Y
11.32x
INTEREST COVERAGE RATIO AVG 15Y
12.05x
INTEREST COVERAGE RATIO AVG 20Y
12.42x
CURRENT VS TTM AVG
-0.82%
CURRENT VS 3Y AVG
-11.80%
CURRENT VS 5Y AVG
-16.23%
CURRENT VS 10Y AVG
-23.20%
CURRENT VS 15Y AVG
-27.90%
CURRENT VS 20Y AVG
-30.01%
SECTOR MEDIAN · HEALTHCARE
6.88x
median of 82 covered companies
CURRENT VS SECTOR MEDIAN
+26.22%
vs the sector median at left
Cencora, Inc.
Market Cap
$62.57B
Interest Coverage Ratio
8.69x
TTM Avg
8.76x
3Y Avg
9.85x
5Y Avg
10.37x
Market Cap
$63.88B
Interest Coverage Ratio
11.38x
TTM Avg
9.10x
3Y Avg
7.54x
5Y Avg
6.16x
Market Cap
$57.13B
Interest Coverage Ratio
-307.40x
TTM Avg
531.75x
3Y Avg
531.75x
5Y Avg
531.75x
Market Cap
$54.94B
Interest Coverage Ratio
7.51x
TTM Avg
9.04x
3Y Avg
12.85x
5Y Avg
10.81x
Market Cap
$74.19B
Interest Coverage Ratio
6.61x
TTM Avg
6.58x
3Y Avg
6.49x
5Y Avg
6.37x
Market Cap
$49.00B
Interest Coverage Ratio
4.21x
TTM Avg
4.38x
3Y Avg
4.79x
5Y Avg
4.28x
Market Cap
$48.58B
Interest Coverage Ratio
N/A
TTM Avg
75.36x
3Y Avg
70.16x
5Y Avg
63.82x
Market Cap
$80.51B
Interest Coverage Ratio
81.69x
TTM Avg
77.00x
3Y Avg
76.06x
5Y Avg
87.20x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cencora, Inc. (COR) | $62.57B | 8.69x | 8.76x | 9.85x | 10.37x |
| Boston Scientific Corporation (BSX)vs › | $63.88B | 11.38x | 9.10x | 7.54x | 6.16x |
| Moderna, Inc. (MRNA)vs › | $57.13B | -307.40x | 531.75x | 531.75x | 531.75x |
| Cardinal Health, Inc. (CAH)vs › | $54.94B | 7.51x | 9.04x | 12.85x | 10.81x |
| Cigna Corporation (CI)vs › | $74.19B | 6.61x | 6.58x | 6.49x | 6.37x |
| Humana Inc. (HUM)vs › | $49.21B | 2.30x | 2.38x | 5.10x | 7.90x |
| Becton, Dickinson and Company (BDX)vs › | $49.00B | 4.21x | 4.38x | 4.79x | 4.28x |
| Edwards Lifesciences Corporation (EW)vs › | $48.58B | N/A | 75.36x | 70.16x | 63.82x |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $80.51B | 81.69x | 77.00x | 76.06x | 87.20x |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $43.20B | 2.35x | 2.35x | 1.39x | 1.57x |
Interest Coverage
8.7x
Debt/Equity
3.84
Current Ratio
0.93
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 7.96x |
| 2026-03-31 | 8.71x |
| 2025-12-31 | 10.89x |
| 2025-09-30 | 7.81x |
| 2025-06-30 | 8.43x |
| 2025-03-31 | 7.68x |
| 2024-12-31 | 12.94x |
| 2024-09-30 | 12.39x |
| 2024-06-30 | 11.93x |
| 2024-03-31 | 11.31x |
| 2023-12-31 | 12.82x |
| 2023-09-30 | 6.92x |
| 2023-06-30 | 8.29x |
| 2023-03-31 | 10.14x |
| 2022-12-31 | 10.41x |
| 2022-09-30 | 8.85x |
| 2022-06-30 | 10.95x |
| 2022-03-31 | 15.47x |
| 2021-12-31 | 12.61x |
| 2021-09-30 | 10.95x |
| 2021-06-30 | 18.77x |
| 2021-03-31 | 19.97x |
| 2020-12-31 | 17.86x |
| 2020-09-30 | 14.76x |
| 2020-06-30 | 11.83x |
| 2020-03-31 | 14.31x |
| 2019-12-31 | 10.39x |
| 2019-09-30 | 7.37x |
| 2019-06-30 | 9.51x |
| 2019-03-31 | 12.45x |
| 2018-12-31 | 8.76x |
| 2018-09-30 | 5.14x |
| 2018-06-30 | 8.12x |
| 2018-03-31 | 10.37x |
| 2017-12-31 | 12.01x |
| 2017-09-30 | 14.02x |
| 2017-06-30 | 12.29x |
| 2017-03-31 | 16.81x |
| 2016-12-31 | 11.05x |
| 2016-09-30 | 13.68x |
| 2016-06-30 | 15.65x |
| 2016-03-31 | 28.02x |
| 2015-12-31 | -5.64x |
| 2015-09-30 | 49.36x |
| 2015-06-30 | 11.16x |
| 2015-03-31 | -15.87x |
| 2014-12-31 | -5.10x |
| 2014-09-30 | 34.77x |
| 2014-06-30 | 24.75x |
| 2014-03-31 | 36.34x |
| 2013-12-31 | 30.06x |
| 2013-09-30 | 11.62x |
| 2013-06-30 | 13.05x |
| 2013-03-31 | 24.47x |
| 2012-12-31 | 20.86x |
| 2012-09-30 | 12.88x |
| 2012-06-30 | 13.96x |
| 2012-03-31 | 16.24x |
| 2011-12-31 | 13.86x |
| 2011-09-30 | 12.07x |
| 2011-06-30 | 16.39x |
| 2011-03-31 | 19.17x |
| 2010-12-31 | 14.46x |
| 2010-09-30 | 13.10x |
| 2010-06-30 | 15.75x |
| 2010-03-31 | 16.14x |
| 2009-12-31 | 15.20x |
| 2009-09-30 | 16.05x |
| 2009-06-30 | 14.54x |
| 2009-03-31 | 15.61x |
| 2008-12-31 | 13.95x |
| 2008-09-30 | 6.03x |
| 2008-06-30 | -5.62x |
| 2008-03-31 | 12.64x |
| 2007-12-31 | 11.87x |
| 2007-09-30 | 4.56x |
| 2007-06-30 | 27.80x |
| 2007-03-31 | -15.27x |
| 2006-12-31 | 25.65x |
| 2006-09-30 | 15.67x |
| 2005-12-31 | 25.58x |
| 2005-03-31 | 12.16x |
| 2004-12-31 | 6.21x |
| 2004-03-31 | 8.37x |
| 2003-12-31 | 6.68x |
| 2003-03-31 | 6.16x |
| 2002-09-30 | 1.38x |